Physician

Andrew B Gentry, M.D.

According to 2025 Medicare claims, Andrew Gentry, M.D. (NPI: 1922072560) practices gastroenterology in the Bozeman, MT market, with the plurality of this provider's patient population coming from Gallatin, MT. This provider's primary affiliated billing organization is BOZEMAN HEALTH DEACONESS HOSPITAL (NPI: 1619347390; TIN: 474717998) and primary practice location at 59715-6902. Gentry is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 43 LLC (ACO ID: A4974), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gentry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 565 traditional Medicare patients, billed 940 HCPCS/CPT codes, and received $116,266 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 414 prescription claims across 116 beneficiaries totaling $800,571 in drug costs, led by Stelara (Ustekinumab). DME data shows 12 claims. Open Payments data shows 15 records totaling $414. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $575,798 to $800,571. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	371	632	$77,337
2016	478	753	$87,011
2017	518	860	$96,881
2018	557	887	$102,675
2019	619	1,036	$122,400
2020	545	913	$102,047
2021	665	1,088	$122,605
2022	602	904	$113,085
2023	616	999	$125,445
2024	565	940	$116,266

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	211	343	$575,798
2016	343	719	$362,678
2017	435	816	$357,133
2018	409	884	$367,582
2019	454	921	$377,690
2020	353	808	$338,072
2021	161	554	$425,066
2022	164	546	$755,269
2023	122	431	$680,580
2024	116	414	$800,571

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$300
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$1,547
2024	N/R	12	$711

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	151	152	$206
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	43	43	$174
45380	Biopsy of large bowel using a flexible endoscope	63	63	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	67	$64
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	98	102	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	17	678	$436,209
Humira(Cf) Pen	Adalimumab	15	420	$101,719
Humira(Cf)	Adalimumab	11	308	$77,873
Mesalamine	Mesalamine	18	1,252	$18,812
Balsalazide Disodium	Balsalazide Disodium	25	1,627	$5,772

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$711

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$414	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew B. Gentry, M.D.?

Tedicare shows public-source Medicare data for Andrew B. Gentry, M.D. (NPI 1922072560), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew B. Gentry, M.D. have ACO affiliation data?

Andrew B. Gentry, M.D. is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Andrew B. Gentry, M.D.?

Andrew B. Gentry, M.D. is linked to BOZEMAN HEALTH DEACONESS HOSPITAL (billing NPI 1619347390) in the available physician profile data.

Does Andrew B. Gentry, M.D. have Open Payments data?

Andrew B. Gentry, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.